9-136432562-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_019892.6(INPP5E):c.1304G>A(p.Arg435Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,397,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_019892.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INPP5E | ENST00000371712.4 | c.1304G>A | p.Arg435Gln | missense_variant | Exon 6 of 10 | 1 | NM_019892.6 | ENSP00000360777.3 | ||
INPP5E | ENST00000676019.1 | c.1202G>A | p.Arg401Gln | missense_variant | Exon 6 of 10 | ENSP00000501984.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000320 AC: 5AN: 156220Hom.: 0 AF XY: 0.0000243 AC XY: 2AN XY: 82332
GnomAD4 exome AF: 0.0000186 AC: 26AN: 1397798Hom.: 0 Cov.: 32 AF XY: 0.0000189 AC XY: 13AN XY: 689494
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Joubert syndrome 1 Pathogenic:2
- -
- -
Familial aplasia of the vermis Pathogenic:2
- -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 435 of the INPP5E protein (p.Arg435Gln). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with Joubert syndrome (PMID: 23386033, 30202406). ClinVar contains an entry for this variant (Variation ID: 399). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt INPP5E protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects INPP5E function (PMID: 19668216). This variant disrupts the p.Arg435 amino acid residue in INPP5E. Other variant(s) that disrupt this residue have been observed in individuals with INPP5E-related conditions (PMID: 25818971, 29230161), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
not specified Pathogenic:1
- -
INPP5E-related disorder Pathogenic:1
The INPP5E c.1304G>A variant is predicted to result in the amino acid substitution p.Arg435Gln. This variant is documented causative for Joubert Syndrome (Bielas et al 2009. PubMed ID: 19668216; Alfares et al. 2018. PubMed ID: 30202406). This variant is reported in 0.0083% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -
MORM syndrome;C4551568:Joubert syndrome 1 Pathogenic:1
- -
not provided Pathogenic:1
- -
Retinal dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at